RMAX vs TECH
Re Max Holding (RMAX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Re Max Holding (RMAX) is a real estate services company listed on NYSE.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported RMAX revenue for 2024-12-31 was $307.7M. Net income was $8.1M. Revenue was down 5.5% from 2023-12-31 to 2024-12-31. RMAX currently screens at market cap $527.7M and trailing P/E 479.5.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
RMAX currently screens at market cap $527.7M and trailing P/E 479.5. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the RMAX and TECH stock pages for the full models.
Not investment advice.